Zkusit zdarma
AbbVie Inc.

AbbVie Inc.

ABBV
Cena:
$ 215.70
+1.20 (0.56%)
Valuace
0
Růst
15
Zdraví
72
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)

8:41 23-05-2026

Holding a high-yield dividend portfolio in a taxable account at the 24% federal bracket means writin...

The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech

The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech

21:15 22-05-2026

When investors take a risk-off attitude, stocks with attractive, growing dividends are often their s...

Healthcare Stocks Are on Fire -- Don't Miss These Opportunities

Healthcare Stocks Are on Fire -- Don't Miss These Opportunities

16:41 22-05-2026

Innovation, regulatory policy, and demographics are driving healthcare stocks higher. Healthcare com...

AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection

AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection

8:00 22-05-2026

The positive opinion is supported by data from the Phase 3 M20-350 study evaluating the safety and e...

The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You

The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You

7:36 22-05-2026

Dividend-growth blue chips like Coca-Cola double income in nine years despite lower starting yields,...

AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline

AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline

18:46 21-05-2026

- Data from novel Top1i ADC and T-cell engager platforms highlight potential within solid tumors and...

Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults

Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults

16:10 21-05-2026

Boey ® has received a positive opinion from the CHMP for 30 EU & EEA markets If approved, Boey ® h...

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

10:01 19-05-2026

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhil...

2 Stocks That Are Much Cheaper Than They Look

2 Stocks That Are Much Cheaper Than They Look

9:30 19-05-2026

Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake f...

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

8:24 19-05-2026

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding ...

2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts

2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts

6:30 19-05-2026

Both offer dividends that yield well above the current S&P 500 index average of 1.1%. The first comp...

Here's How Neuroscience Drugs Boost AbbVie's Q1 Sales Growth

Here's How Neuroscience Drugs Boost AbbVie's Q1 Sales Growth

13:20 18-05-2026

ABBV's neuroscience sales jump 26% in Q1, driven by Vraylar, migraine drugs and Botox as new therapi...

How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?

How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?

12:01 15-05-2026

ABBV's Q1 beat is powered by Skyrizi and Rinvoq, whose strong sales growth offset Humira declines an...

Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now

Realty Income Has Raised Its Dividend 113 Consecutive Times. Here Is Why That Is Not Enough to Own It Right Now

11:40 15-05-2026

Realty Income (...

AbbVie Inc. (ABBV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

AbbVie Inc. (ABBV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

20:30 13-05-2026

AbbVie Inc. (ABBV) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

AbbVie Inc (ABBV) Stock Up 3.1% and Still Undervalued -- GF Score: 86/100

AbbVie Inc (ABBV) Stock Up 3.1% and Still Undervalued -- GF Score: 86/100

17:18 12-05-2026

On May 12, 2026, AbbVie Inc (ABBV) shares rose 3.1% today, reaching a current price of $207.98. The ...

AbbVie's Growth Engine Is Firing On All Cylinders

AbbVie's Growth Engine Is Firing On All Cylinders

10:30 12-05-2026

AbbVie is a compelling 'Buy' as it has strong momentum in existing drugs and has a robust pipeline. ...

3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow

3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow

10:30 12-05-2026

How does a rising 3.4% dividend and a growing portfolio of drugs sound?...

AbbVie Deserves A Higher Multiple

AbbVie Deserves A Higher Multiple

23:08 11-05-2026

AbbVie remains a buy as fundamentals strengthen and valuation sits near multiyear lows after recent ...

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

17:15 11-05-2026

AbbVie's Skyrizi is one of its most important growth drivers. This drug could face competition from ...

close

ABBVIE REPORTS FULL-YEAR AND FOURTH-QUARTER 2025 FINANCIAL RESULTS

04-02-2026
REPORTS FULL-YEAR DILUTED EPS OF $2.36 ON A GAAP BASIS, A DECREASE OF 1.3 PERCENT; ADJUSTED DILUTED ...
Více zde

ALLERGAN AESTHETICS CONTINUES ITS MISSION OF EMPOWERING WOMEN THROUGH THE FACES OF NATRELLE® TESTIMONIAL PROGRAM

03-02-2026
THE NATIONWIDE PROGRAM INVITES ELIGIBLE NATRELLE® BREAST AUGMENTATION AND RECONSTRUCTION PATIENTS T...
Více zde

ABBVIE SUBMITS REGULATORY APPLICATIONS TO FDA AND EMA FOR UPADACITINIB (RINVOQ®) IN ADULTS AND ADOLESCENTS WITH VITILIGO

03-02-2026
SUBMISSIONS ARE SUPPORTED BY DATA FROM THE PHASE 3 VITI-UP CLINICAL STUDIES DEMONSTRATING UPADACITI...
Více zde

ABBVIE LAUNCHES LOVE IN MIND™ TO SPOTLIGHT THE EMOTIONAL IMPACT OF MIGRAINE ON ROMANTIC RELATIONSHIPS

29-01-2026
~3 OUT OF 4 RESPONDENTS SAID MIGRAINE ATTACKS HAVE STOOD IN THE WAY OF ROMANTIC RELATIONSHIPS, ACCOR...
Více zde

ALLERGAN AESTHETICS UNVEILS NEW DATA ACROSS FACIAL INJECTABLES ON-MARKET AND EMERGING PORTFOLIO AT IMCAS 2026 SHOWCASING ENDURING STRENGTH IN ADVANCING AESTHETICS MEDICINE

28-01-2026
-  N INE E-POSTERS PRESENTING COMPREHENSIVE ALLERGAN AESTHETICS PORTFOLIO DATA SPANNING FIRST-IN-CL...
Více zde

THE ABBVIE FOUNDATION IS NOW ACCEPTING APPLICATIONS TO PARTICIPATE IN THE 2026 ABBVIE FOUNDATION HEALTH EQUITY ACCELERATOR

27-01-2026
CHICAGO--(BUSINESS WIRE)--THE ABBVIE FOUNDATION, A 501(C)(3) NONPROFIT WORKING TO DRIVE TRANSFORMATI...
Více zde

ABBVIE ANNOUNCES TOPLINE RESULTS FOR EPCORITAMAB (DUOBODY® CD3XCD20) FROM PHASE 3 EPCORE® DLBCL-1 TRIAL IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

16-01-2026
BASED ON THE TOPLINE RESULTS FROM THE EPCORE® DLBCL-1 TRIAL, ABBVIE ALONG WITH PARTNER GENMAB WILL ...
Více zde

ABBVIE AND TRUMP ADMINISTRATION REACH AGREEMENT TO IMPROVE ACCESS AND AFFORDABILITY FOR AMERICANS

12-01-2026
ABBVIE WILL PROVIDE LOW PRICES IN MEDICAID, AND EXPAND AFFORDABLE, DIRECT-TO-PATIENT OFFERINGS FOR T...
Více zde

ABBVIE AND REMEGEN ANNOUNCE EXCLUSIVE LICENSING AGREEMENT TO DEVELOP A NOVEL BISPECIFIC ANTIBODY FOR ADVANCED SOLID TUMORS

12-01-2026
-       RC148 IS A NOVEL PD-1/VEGF BISPECIFIC ANTIBODY BEING EVALUATED IN MULTIPLE ADVANCED SO...
Více zde

WEST SIGNS AGREEMENT TO SELL THE MANUFACTURING AND SUPPLY RIGHTS FOR SMARTDOSE® 3.5ML ON-BODY DELIVERY SYSTEM TO ABBVIE

12-01-2026
EXTON, PA., JAN. 12, 2026 /PRNEWSWIRE/ -- WEST PHARMACEUTICAL SERVICES, INC. (NYSE: WST), A GLOBAL L...
Více zde

ABBVIE TO HOST FULL-YEAR AND FOURTH-QUARTER 2025 EARNINGS CONFERENCE CALL

07-01-2026
NORTH CHICAGO, ILL., JAN. 7, 2026 /PRNEWSWIRE/ -- ABBVIE (NYSE: ABBV) WILL ANNOUNCE ITS FULL-YEAR AN...
Více zde

ABBVIE TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

05-01-2026
NORTH CHICAGO, ILL., JAN. 5, 2026 /PRNEWSWIRE/ -- ABBVIE (NYSE: ABBV) WILL PRESENT AT THE 44TH ANNUA...
Více zde

OSE IMMUNOTHERAPEUTICS ANNOUNCES STRATEGIC AMENDMENT TO ABBVIE'S PARTNERSHIP ON ABBV-230 DEVELOPMENT

08-12-2025
OSE IMMUNOTHERAPEUTICS ANNOUNCES STRATEGIC AMENDMENT TO ABBVIE'S PARTNERSHIP ON ABBV-230 DEVELOPMENT...
Více zde

ABBVIE TO FEATURE NEW DATA AT ASH 2025 SHOWCASING CONTINUED ADVANCES ACROSS NOVEL TREATMENT MODALITIES IN MULTIPLE BLOOD CANCERS

02-12-2025
DATA BEING PRESENTED SHOWCASES ABBVIE'S BREADTH AND DEPTH OF RESEARCH ACROSS A RANGE OF THERAPEUTIC ...
Více zde

SKYRIZI® (RISANKIZUMAB) RECEIVES POSITIVE REIMBURSEMENT RECOMMENDATION BY CANADA'S DRUG AGENCY FOR ULCERATIVE COLITIS AND ABBVIE CONCLUDES LETTER OF INTENT WITH THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE

28-11-2025
MONTREAL, NOV. 28, 2025 (GLOBE NEWSWIRE) -- TODAY, ABBVIE (NYSE: ABBV) HAS ANNOUNCED TWO POSITIVE UP...
Více zde

ABBVIE AND ADMARE BIOINNOVATIONS FOSTER LIFE SCIENCES INNOVATION WITH THE LAUNCH OF THE ABBVIE BIOTECH INNOVATORS AWARD IN QUEBEC

25-11-2025
MONTREAL, NOV. 25, 2025 (GLOBE NEWSWIRE) -- TODAY, ABBVIE (NYSE: ABBV), JOINTLY WITH THE ADMARE BIOI...
Více zde

ABBVIE TO PRESENT AT THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE

24-11-2025
NORTH CHICAGO, ILL. , NOV. 24, 2025 /PRNEWSWIRE/ -- ABBVIE (NYSE: ABBV) WILL PARTICIPATE IN THE PIPE...
Více zde

ABBVIE ANNOUNCES U.S. FDA APPROVAL OF EPKINLY® (EPCORITAMAB-BYSP) IN COMBINATION WITH RITUXIMAB AND LENALIDOMIDE FOR RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

18-11-2025
-   EPKINLY PLUS RITUXIMAB AND LENALIDOMIDE (EPKINLY + R2)  IS NOW THE FIRST AND ONLY BISPECIFIC ...
Více zde

ABBVIE ANNOUNCES 20 RECIPIENTS OF MIGRAINE CAREER CATALYST AWARD™

13-11-2025
AS A LEADER IN MIGRAINE TREATMENT, ABBVIE IS COMMITTED TO ADDRESSING THE IMPACT OF MIGRAINE IN THE W...
Více zde

ALLERGAN AESTHETICS UNVEILS NEW DATA AT 2025 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ANNUAL MEETING SHOWCASING TRANSFORMATIVE INNOVATION AND PORTFOLIO EXCELLENCE

12-11-2025
- A TOTAL OF 17 ABSTRACTS, INCLUDING THREE ACCEPTED FOR PRESENTATION IN THE COSMETIC "TOP TEN" SESS...
Více zde

ABBVIE REPORTS THIRD-QUARTER 2025 FINANCIAL RESULTS

31-10-2025
REPORTS THIRD-QUARTER DILUTED EPS OF $0.10 ON A GAAP BASIS, A DECREASE OF 88.6 PERCENT; ADJUSTED DIL...
Více zde

THE ONE & ONLY BOTOX® COSMETIC (ONABOTULINUMTOXINA) DAY RETURNS NOVEMBER 19 WITH THE BIGGEST CELEBRATION OF THE YEAR

29-10-2025
ALLERGAN AESTHETICS GIVES PATIENTS EXCITING BOTOX® COSMETIC OFFERS ONLY IN THE ALLĒ APP BUY ONE $5...
Více zde

ABBVIE ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 PIVOTAL STUDIES EVALUATING UPADACITINIB (RINVOQ®) IN ADULTS AND ADOLESCENTS WITH VITILIGO

29-10-2025
IN TWO REPLICATE PHASE 3 STUDIES, UPADACITINIB (RINVOQ ® ) ACHIEVED THE CO-PRIMARY ENDPOINTS OF 50%...
Více zde

THE CONFIDENCE PROJECT BY BOTOX® COSMETIC (ONABOTULINUMTOXINA) UNVEILS THIS YEAR'S GRANT RECIPIENTS

21-10-2025
EACH WINNER WILL BE AWARDED A $20,000 GRANT TO FUEL THEIR BUSINESSES. SINCE THE PROGRAM'S INCEPTION,...
Více zde

RINVOQ® (UPADACITINIB) DEMONSTRATED SUPERIORITY VERSUS HUMIRA® (ADALIMUMAB) FOR PRIMARY ENDPOINT IN A HEAD-TO-HEAD STUDY IN RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED FIRST TNF INHIBITOR

20-10-2025
UPADACITINIB DEMONSTRATED SUPERIORITY VERSUS ADALIMUMAB FOR  PRIMARY ENDPOINT OF ACHIEVING LOW DISE...
Více zde

ABBVIE COMPLETES ACQUISITION OF GILGAMESH PHARMACEUTICALS' BRETISILOCIN

17-10-2025
ACQUISITION EXPANDS ABBVIE'S PSYCHIATRY PIPELINE WITH THE ADDITION OF A NEXT-GENERATION PSYCHEDELIC...
Více zde

ENVERIC BIOSCIENCES HIRES IP POWERHOUSE TO DEFEND ITS U.S. PATENT WITH CLAIMS RELEVANT TO BRETISILOCIN, RECENTLY ACQUIRED BY ABBVIE IN $1.2 BILLION DEAL

15-10-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)--ENVERIC BIOSCIENCES (NASDAQ: ENVB) (“ENVERIC” OR THE “COMPA...
Více zde

U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVES UPDATED INDICATION STATEMENT FOR RINVOQ® (UPADACITINIB) FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

13-10-2025
-        UPDATED INDICATION ALLOWS THE USE OF RINVOQ® (UPADACITINIB) PRIOR TO THE USE OF TUMOR ...
Více zde

ABBVIE TO PRESENT NEW DATA AT ESMO 2025 REINFORCING LEADERSHIP IN ADVANCING TARGETED THERAPIES FOR SOLID TUMORS

13-10-2025
NEW DATA FROM TELISOTUZUMAB ADIZUTECAN (TEMAB-A) AND ABBV-706 ACROSS PANCREATIC, COLORECTAL, AND SO...
Více zde

SKINMEDICA® DEBUTS REIMAGINED PACKAGING AND UNVEILS NEW HA5® HYDRA COLLAGEN WATER BURST MOISTURIZER

09-10-2025
BY THE MAKERS OF BOTOX® COSMETIC (ONABOTULINUMTOXINA), SKINMEDICA®'S NEW PACKAGING FEATURES A REFR...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-04 00:00:008-KStáhnout
2026-01-07 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-10-31 00:00:008-KStáhnout
2025-10-03 01:00:008-KStáhnout
2025-10-03 00:00:008-KStáhnout
2025-09-11 01:00:008-KStáhnout
2025-09-11 00:00:008-KStáhnout
2025-08-04 01:00:0010-QStáhnout
2025-08-04 00:00:0010-QStáhnout
2025-07-31 01:00:008-KStáhnout
2025-07-31 00:00:008-KStáhnout
2025-07-03 01:00:008-KStáhnout
2025-07-03 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-09 01:00:0010-QStáhnout
2025-05-09 00:00:0010-QStáhnout
2025-04-25 01:00:008-KStáhnout
2025-04-25 00:00:008-KStáhnout
2025-04-03 01:00:008-KStáhnout
2025-04-03 00:00:008-KStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-02-19 00:00:008-KStáhnout
2025-02-18 23:00:008-KStáhnout
2025-02-14 00:00:008-KStáhnout
2025-02-14 00:00:0010-KStáhnout
2025-02-13 23:00:008-KStáhnout
2025-02-13 23:00:0010-KStáhnout
2025-02-05 00:00:008-KStáhnout
2025-02-04 23:00:008-KStáhnout
2025-01-31 00:00:008-KStáhnout
2025-01-30 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2025-01-06 00:00:008-KStáhnout
2025-01-05 23:00:008-KStáhnout
2024-12-13 00:00:008-KStáhnout
2024-12-12 23:00:008-KStáhnout
2024-11-04 00:00:0010-QStáhnout
2024-11-03 23:00:0010-QStáhnout
2024-10-30 00:00:008-KStáhnout
2024-10-29 23:00:008-KStáhnout
2024-10-03 01:00:008-KStáhnout
2024-10-03 00:00:008-KStáhnout
2024-09-10 01:00:008-KStáhnout
2024-09-10 00:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-07-25 01:00:008-KStáhnout
2024-07-25 00:00:008-KStáhnout
2024-07-03 01:00:008-KStáhnout
2024-07-03 00:00:008-KStáhnout
2024-05-03 01:00:0010-QStáhnout
2024-05-03 00:00:0010-QStáhnout
2024-04-26 01:00:008-KStáhnout
2024-04-26 00:00:008-KStáhnout
2024-04-03 01:00:008-KStáhnout
2024-04-03 00:00:008-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-02-20 00:00:008-KStáhnout
2024-02-20 00:00:0010-KStáhnout
2024-02-19 23:00:008-KStáhnout
2024-02-19 23:00:0010-KStáhnout
2024-02-12 00:00:008-KStáhnout
2024-02-11 23:00:008-KStáhnout
2024-02-02 00:00:008-KStáhnout
2024-02-01 23:00:008-KStáhnout
2024-01-05 00:00:008-KStáhnout
2024-01-04 23:00:008-KStáhnout
2023-12-06 00:00:008-KStáhnout
2023-12-05 23:00:008-KStáhnout
2023-11-30 00:00:008-KStáhnout
2023-11-29 23:00:008-KStáhnout
2023-11-06 00:00:0010-QStáhnout
2023-11-05 23:00:0010-QStáhnout
2023-10-27 01:00:008-KStáhnout
2023-10-27 00:00:008-KStáhnout
2023-10-12 01:00:008-KStáhnout
2023-10-12 00:00:008-KStáhnout
2023-10-04 01:00:008-KStáhnout
2023-10-04 00:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-07-27 01:00:008-KStáhnout
2023-07-27 00:00:008-KStáhnout
2023-07-06 01:00:008-KStáhnout
2023-07-06 00:00:008-KStáhnout
2023-06-29 01:00:008-KStáhnout
2023-06-29 00:00:008-KStáhnout
2023-05-10 01:00:008-KStáhnout
2023-05-10 00:00:008-KStáhnout
2023-05-05 01:00:0010-QStáhnout
2023-05-05 00:00:0010-QStáhnout
2023-04-27 01:00:008-KStáhnout
2023-04-27 00:00:008-KStáhnout
2023-04-05 01:00:008-KStáhnout
2023-04-05 00:00:008-KStáhnout
2023-03-28 01:00:008-KStáhnout
2023-03-28 00:00:008-KStáhnout
2023-02-17 00:00:0010-KStáhnout
2023-02-16 23:00:0010-KStáhnout
2023-02-09 00:00:008-KStáhnout
2023-02-08 23:00:008-KStáhnout
2023-01-10 00:00:008-KStáhnout
2023-01-09 23:00:008-KStáhnout
2023-01-06 00:00:008-KStáhnout
2023-01-05 23:00:008-KStáhnout
2022-11-29 00:00:008-KStáhnout
2022-11-28 23:00:008-KStáhnout
2022-11-04 00:00:0010-QStáhnout
2022-11-03 23:00:0010-QStáhnout
2022-10-28 01:00:008-KStáhnout
2022-10-28 00:00:008-KStáhnout
2022-10-17 01:00:008-KStáhnout
2022-10-17 00:00:008-KStáhnout
2022-10-14 01:00:008-KStáhnout
2022-10-14 00:00:008-KStáhnout
2022-10-05 01:00:008-KStáhnout
2022-10-05 00:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-07-29 01:00:008-KStáhnout
2022-07-29 00:00:008-KStáhnout
2022-07-06 01:00:008-KStáhnout
2022-07-06 00:00:008-KStáhnout
2022-06-29 01:00:008-KStáhnout
2022-06-29 00:00:008-KStáhnout
2022-06-28 01:00:008-KStáhnout
2022-06-28 00:00:008-KStáhnout
2022-05-11 01:00:008-KStáhnout
2022-05-11 00:00:008-KStáhnout
2022-05-06 01:00:0010-QStáhnout
2022-05-06 00:00:0010-QStáhnout
2022-04-29 01:00:008-KStáhnout
2022-04-29 00:00:008-KStáhnout
2022-04-21 01:00:008-KStáhnout
2022-04-21 00:00:008-KStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-03-04 00:00:008-KStáhnout
2022-03-03 23:00:008-KStáhnout
2022-02-18 00:00:0010-KStáhnout
2022-02-17 23:00:0010-KStáhnout
2022-02-02 00:00:008-KStáhnout
2022-02-01 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-12-16 00:00:008-KStáhnout
2021-12-15 23:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-10-29 01:00:008-KStáhnout
2021-10-29 00:00:008-KStáhnout
2021-08-19 01:00:008-KStáhnout
2021-08-19 00:00:008-KStáhnout
2021-08-02 01:00:0010-QStáhnout
2021-08-02 00:00:0010-QStáhnout
2021-07-30 01:00:008-KStáhnout
2021-07-30 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-07 01:00:0010-QStáhnout
2021-05-07 00:00:0010-QStáhnout
2021-04-30 01:00:008-KStáhnout
2021-04-30 00:00:008-KStáhnout
2021-04-20 01:00:008-KStáhnout
2021-04-20 00:00:008-KStáhnout
2021-03-12 00:00:008-KStáhnout
2021-03-11 23:00:008-KStáhnout
2021-02-19 00:00:0010-KStáhnout
2021-02-18 23:00:0010-KStáhnout
2021-02-03 00:00:008-KStáhnout
2021-02-02 23:00:008-KStáhnout
2021-01-12 00:00:008-KStáhnout
2021-01-11 23:00:008-KStáhnout
2021-01-06 00:00:008-KStáhnout
2021-01-05 23:00:008-KStáhnout
2020-11-18 00:00:008-KStáhnout
2020-11-17 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-04 00:00:0010-QStáhnout
2020-11-03 23:00:0010-QStáhnout
2020-10-30 00:00:008-KStáhnout
2020-10-29 23:00:008-KStáhnout
2020-10-19 01:00:008-KStáhnout
2020-10-19 00:00:008-KStáhnout
2020-10-02 01:00:008-KStáhnout
2020-10-02 00:00:008-KStáhnout
2020-08-04 01:00:0010-QStáhnout
2020-08-04 00:00:0010-QStáhnout
2020-07-31 01:00:008-KStáhnout
2020-07-31 00:00:008-KStáhnout
2020-07-29 01:00:008-KStáhnout
2020-07-29 00:00:008-KStáhnout
2020-05-14 01:00:008-KStáhnout
2020-05-14 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-08 01:00:008-KStáhnout
2020-05-08 01:00:0010-QStáhnout
2020-05-08 00:00:008-KStáhnout
2020-05-08 00:00:0010-QStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-05-01 01:00:008-KStáhnout
2020-05-01 00:00:008-KStáhnout
2020-04-27 01:00:008-KStáhnout
2020-04-27 00:00:008-KStáhnout
2020-04-20 01:00:008-KStáhnout
2020-04-20 00:00:008-KStáhnout
2020-04-06 01:00:008-KStáhnout
2020-04-06 00:00:008-KStáhnout
2020-03-23 00:00:008-KStáhnout
2020-03-22 23:00:008-KStáhnout
2020-03-09 00:00:008-KStáhnout
2020-03-08 23:00:008-KStáhnout
2020-02-24 00:00:008-KStáhnout
2020-02-23 23:00:008-KStáhnout
2020-02-21 00:00:0010-KStáhnout
2020-02-20 23:00:0010-KStáhnout
2020-02-14 00:00:008-KStáhnout
2020-02-13 23:00:008-KStáhnout
2020-02-07 00:00:008-KStáhnout
2020-02-06 23:00:008-KStáhnout
2020-01-27 00:00:008-KStáhnout
2020-01-26 23:00:008-KStáhnout
2019-12-20 00:00:008-KStáhnout
2019-12-19 23:00:008-KStáhnout
2019-11-26 00:00:008-KStáhnout
2019-11-25 23:00:008-KStáhnout
2019-11-18 00:00:008-KStáhnout
2019-11-17 23:00:008-KStáhnout
2019-11-13 00:00:008-KStáhnout
2019-11-12 23:00:008-KStáhnout
2019-11-08 00:00:008-KStáhnout
2019-11-07 23:00:008-KStáhnout
2019-11-07 00:00:008-KStáhnout
2019-11-06 23:00:008-KStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-06 00:00:0010-QStáhnout
2019-11-05 23:00:008-KStáhnout
2019-11-05 23:00:0010-QStáhnout
2019-11-01 00:00:008-KStáhnout
2019-10-31 23:00:008-KStáhnout
2019-10-25 01:00:008-KStáhnout
2019-10-25 00:00:008-KStáhnout
2019-10-22 01:00:008-KStáhnout
2019-10-22 00:00:008-KStáhnout
2019-09-26 01:00:008-KStáhnout
2019-09-26 00:00:008-KStáhnout
2019-09-23 01:00:008-KStáhnout
2019-09-23 00:00:008-KStáhnout
2019-09-16 01:00:008-KStáhnout
2019-09-16 00:00:008-KStáhnout
2019-08-30 01:00:008-KStáhnout
2019-08-30 00:00:008-KStáhnout
2019-08-05 01:00:0010-QStáhnout
2019-08-05 00:00:0010-QStáhnout
2019-07-26 01:00:008-KStáhnout
2019-07-26 00:00:008-KStáhnout
2019-07-16 01:00:008-KStáhnout
2019-07-16 00:00:008-KStáhnout
2019-06-25 01:00:008-KStáhnout
2019-06-25 00:00:008-KStáhnout
2019-05-06 01:00:008-KStáhnout
2019-05-06 00:00:008-KStáhnout
2019-05-03 01:00:0010-QStáhnout
2019-05-03 00:00:0010-QStáhnout
2019-04-25 01:00:008-KStáhnout
2019-04-25 00:00:008-KStáhnout
2019-02-27 00:00:0010-KStáhnout
2019-02-26 23:00:0010-KStáhnout
2019-01-25 00:00:008-KStáhnout
2019-01-24 23:00:008-KStáhnout
2019-01-04 00:00:008-KStáhnout
2019-01-03 23:00:008-KStáhnout
2018-12-17 00:00:008-KStáhnout
2018-12-16 23:00:008-KStáhnout
2018-11-07 00:00:0010-QStáhnout
2018-11-06 23:00:0010-QStáhnout
2018-11-02 00:00:008-KStáhnout
2018-11-01 23:00:008-KStáhnout
2018-10-19 01:00:008-KStáhnout
2018-10-19 00:00:008-KStáhnout
2018-09-18 01:00:008-KStáhnout
2018-09-18 00:00:008-KStáhnout
2018-09-06 01:00:008-KStáhnout
2018-09-06 00:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-07-27 01:00:008-KStáhnout
2018-07-27 00:00:008-KStáhnout
2018-05-18 01:00:008-KStáhnout
2018-05-18 00:00:008-KStáhnout
2018-05-08 01:00:008-KStáhnout
2018-05-08 00:00:008-KStáhnout
2018-05-04 01:00:0010-QStáhnout
2018-05-04 00:00:0010-QStáhnout
2018-05-01 01:00:008-KStáhnout
2018-05-01 00:00:008-KStáhnout
2018-04-26 01:00:008-KStáhnout
2018-04-26 00:00:008-KStáhnout
2018-02-16 00:00:0010-KStáhnout
2018-02-15 23:00:0010-KStáhnout
2018-01-26 00:00:008-KStáhnout
2018-01-25 23:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-10-27 01:00:008-KStáhnout
2017-10-27 00:00:008-KStáhnout
2017-08-07 01:00:0010-QStáhnout
2017-08-07 00:00:0010-QStáhnout
2017-07-28 01:00:008-KStáhnout
2017-07-28 00:00:008-KStáhnout
2017-05-09 01:00:008-KStáhnout
2017-05-09 00:00:008-KStáhnout
2017-05-05 01:00:0010-QStáhnout
2017-05-05 00:00:0010-QStáhnout
2017-04-27 01:00:008-KStáhnout
2017-04-27 00:00:008-KStáhnout
2017-02-17 00:00:0010-KStáhnout
2017-02-16 23:00:0010-KStáhnout
2017-01-27 00:00:008-KStáhnout
2017-01-26 23:00:008-KStáhnout
2017-01-05 00:00:008-KStáhnout
2017-01-04 23:00:008-KStáhnout
2016-11-17 00:00:008-KStáhnout
2016-11-16 23:00:008-KStáhnout
2016-11-07 00:00:0010-QStáhnout
2016-11-06 23:00:0010-QStáhnout
2016-10-28 01:00:008-KStáhnout
2016-10-28 00:00:008-KStáhnout
2016-10-14 01:00:008-KStáhnout
2016-10-14 00:00:008-KStáhnout
2016-08-05 01:00:0010-QStáhnout
2016-08-05 00:00:0010-QStáhnout
2016-07-29 01:00:008-KStáhnout
2016-07-29 00:00:008-KStáhnout
2016-06-08 01:00:008-KStáhnout
2016-06-08 00:00:008-KStáhnout
2016-06-02 01:00:008-KStáhnout
2016-06-02 00:00:008-KStáhnout
2016-06-01 01:00:008-KStáhnout
2016-06-01 00:00:008-KStáhnout
2016-05-12 01:00:008-KStáhnout
2016-05-12 00:00:008-KStáhnout
2016-05-10 01:00:008-KStáhnout
2016-05-10 00:00:008-KStáhnout
2016-05-06 01:00:0010-QStáhnout
2016-05-06 00:00:0010-QStáhnout
2016-04-29 01:00:008-KStáhnout
2016-04-29 00:00:008-KStáhnout
2016-04-28 01:00:008-KStáhnout
2016-04-28 00:00:008-KStáhnout
2016-02-22 00:00:008-KStáhnout
2016-02-21 23:00:008-KStáhnout
2016-02-19 00:00:0010-KStáhnout
2016-02-18 23:00:0010-KStáhnout
2016-01-29 00:00:008-KStáhnout
2016-01-28 23:00:008-KStáhnout
2015-11-06 00:00:0010-QStáhnout
2015-11-05 23:00:0010-QStáhnout
2015-10-30 00:00:008-KStáhnout
2015-10-29 23:00:008-KStáhnout
2015-09-29 01:00:008-KStáhnout
2015-09-29 00:00:008-KStáhnout
2015-08-07 01:00:0010-QStáhnout
2015-08-07 00:00:0010-QStáhnout
2015-07-24 01:00:008-KStáhnout
2015-07-24 00:00:008-KStáhnout
2015-05-27 01:00:008-KStáhnout
2015-05-27 00:00:008-KStáhnout
2015-05-26 01:00:008-KStáhnout
2015-05-26 00:00:008-KStáhnout
2015-05-14 01:00:008-KStáhnout
2015-05-14 00:00:008-KStáhnout
2015-05-11 01:00:008-KStáhnout
2015-05-11 00:00:008-KStáhnout
2015-05-08 01:00:0010-QStáhnout
2015-05-08 00:00:0010-QStáhnout
2015-05-07 01:00:008-KStáhnout
2015-05-07 00:00:008-KStáhnout
2015-04-23 01:00:008-KStáhnout
2015-04-23 00:00:008-KStáhnout
2015-03-30 00:00:008-KStáhnout
2015-03-22 23:00:008-KStáhnout
2015-03-19 23:00:008-KStáhnout
2015-03-05 23:00:008-KStáhnout
2015-03-04 23:00:008-KStáhnout
preloader